A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC

Beijing Cancer Hospital, Beijing

Jilin Cancer Hospital, Changchun

The First Affiliated Hospital of Chongqing Medical University, Chongqing

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

Zhejiang Cancer Hospital, Hangzhou

Harbin Medical University Cancer Hospital, Harbin

Anhui Provincial Hospital, Hefei

Central Hospital Affiliated To Shandong First Medical University, Jinan

Hebei Petro China Central Hospital, Langfang

Linyi Cancer Hospital, Linyi

The First Affiliated Hospital of Nanchang University, Nanchang

The Affiliated Hospital of Qingdao University, Qingdao

Shandong Cancer Hospital, Shandong

Shanghai Pulmonary Hospital, Shanghai

Taizhou Hospital of Zhejiang Province, Taizhou

Tianjin Medical University General Hospital, Tianjin

The First Affiliated Hospital of Zhengzhou University, Zhengzhou